Applicant profile

Bard Peripheral Vascular, Inc.

Bard Peripheral Vascular, Inc.
Hong Kong MDACS·United States·12 registered devices·Feb 23, 2016Sep 02, 2024
12
Total devices
3
Risk classes
2016
First registration
2024
Most recent
Applicant overview
Bilingual manufacturer details sourced from Hong Kong MDACS
Applicant (EN)
Bard Peripheral Vascular, Inc.
Applicant (ZH)
Bard Peripheral Vascular, Inc.
Country
United States
美国
Address
1625 West 3rd Street, Tempe, Arizona, 85281, USA
1625西三街, 坦佩, 亚利桑那州, 85281, 美国
Timeline
First registration
Feb 23, 2016
Most recent
Sep 02, 2024
Risk class breakdown
II
6
III
1
IV
5
Recent MDACS registrations
Latest 15 devices linked to this applicant
DeviceRisk classAuthorised repRegistered
Catheters, Vascular, Angioplasty, Balloon
导管、血管、血管成形术、球囊
IVBecton Dickinson Asia Limited
碧迪亚洲有限公司
Sep 02, 2024
Biopsy Guns, End-Cut
活检枪,端切
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
May 22, 2024
Catheters, Vascular, Angioplasty, Balloon
导管、血管、血管成形术、球囊
IVBecton Dickinson Asia Limited
碧迪亚洲有限公司
Apr 18, 2024
Filters, Vena Cava
过滤器,腔静脉
IVBecton Dickinson Asia Limited
碧迪亚洲有限公司
Mar 07, 2024
Lesion Localization Wires
病变定位导线
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Feb 08, 2023
Stent/Grafts, Vascular
支架/移植物,血管
IIIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Jan 19, 2022
Biopsy Guns, End-Cut, Disposable
活检枪,端切,一次性
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Jan 19, 2022
Biopsy Guns, End-Cut
活检枪,端切
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Jan 19, 2022
Biopsy Guns, End-Cut, Disposable
活检枪,端切,一次性
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Jan 04, 2022
Catheters, Cardiac, Valvuloplasty
导管、心脏导管、瓣膜成形术
IVBecton Dickinson Asia Limited
碧迪亚洲有限公司
Dec 10, 2021
Needles, Lesion Localization, Breast
针头、病变定位、乳房
IIBecton Dickinson Asia Limited
碧迪亚洲有限公司
Dec 04, 2020
Catheters, Vascular, Angioplasty, Balloon
导管、血管、血管成形术、球囊
IVBard Hong Kong LimitedFeb 23, 2016
About this profile

Bard Peripheral Vascular, Inc. is associated with 12 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.